To hear about similar clinical trials, please enter your email below
Trial Title:
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
NCT ID:
NCT06090825
Condition:
Pancreatic Cancer
Conditions: Official terms:
Pancreatic Neoplasms
Conditions: Keywords:
follow up
palliative care
pancreatic cancer
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Other
Intervention name:
Observational study
Description:
Observational study
Arm group label:
Pancreatic cancer patients
Summary:
It is a real-world observational cross-sectional follow-up study on clinical palliative
care for pancreatic cancer patients in China. It is evaluated by an online questionnaire
sent to the doctors from the General Surgery Department in more than 100 public tertiary
teaching hospitals and about 350 public primary care units in the Chinese mainland.
Detailed description:
Pancreatic cancer is a highly malignant gastrointestinal tumor with only a 10% overall
5-year survival rate. More than 80% of patients are already in the advanced stage when
diagnosed, losing the chance of surgery. Advanced pancreatic cancer progresses rapidly
and chemoradiotherapy has limited efficacy, so palliative care is thought to play an
important role in the treatment process. However, due to the late development of
palliative care, there is a lack of data on real-world clinical palliative care for
pancreatic cancer patients in China.
This study investigates the real-world current status of palliative care for pancreatic
cancer patients by sending a web questionnaire to the doctors from the Department of
General Surgery in more than 100 public tertiary teaching hospitals and about 350 public
primary care units in the Chinese mainland. The survey aims to obtain the real status of
palliative care and achieve a comprehensive understanding of how to develop palliative
care in hospitals.
The questionnaire includes both subjective standards like the surgeons' opinion on the
development of palliative therapy and objective standards such as dedicated beds and
teams for palliative care.
Criteria for eligibility:
Study pop:
The doctors of the Department of General Surgery in more than 100 public tertiary
teaching hospitals and about 350 public primary care units in the Chinese mainland
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Doctors from the General Surgery Department in Chinese public tertiary teaching
hospitals and public primary care units
- Approval to participate
- Participants with a valid and complete questionnaire evaluated by 2 experienced
surgeons
Exclusion Criteria:
- Refusal to participate
- Participants with an invalid or incomplete questionnaire
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Peking Union Medical College Hospital
Address:
City:
Beijing
Zip:
100730
Country:
China
Status:
Recruiting
Contact:
Last name:
Qiaofei Liu, MD
Investigator:
Last name:
Qiaofei Liu, MD
Email:
Principal Investigator
Start date:
September 1, 2023
Completion date:
September 1, 2025
Lead sponsor:
Agency:
Peking Union Medical College Hospital
Agency class:
Other
Source:
Peking Union Medical College Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06090825
